Rosacea and small intestinal bacterial overgrowth: Prevalence and response to rifaximin

Journal of the American Academy of Dermatology

Volumn 68, Issue 5, 2013, Pages 875-876

  Weinstock, Leonard B ^a,b   Steinhoff, Martin ^c  

^a Specialists in Gastroenterology LLC   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; LACTULOSE; RIFAXIMIN; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; BACTERIAL OVERGROWTH; BREATH ANALYSIS; COLONOSCOPY; CONFIDENCE INTERVAL; DRUG EFFICACY; FACE ERYTHEMA; HUMAN; INNATE IMMUNITY; INTESTINE FLORA; LETTER; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PILOT STUDY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; ROSACEA; SELF REPORT; TH1 CELL;

EID: 84876396664     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2012.11.038     Document Type: Article

References (4)

1. V.D. Schwab, M. Sulk, S. Seeliger, P. Nowak, J. Aubert, and C. Mess Neurovascular and neuroimmune aspects in the pathophysiology of rosacea J Invest Dermatol Symp Proc 15 2011 53 62
2. A. Parodi, S. Paolino, A. Greco, F. Drago, C. Mansi, and A. Rebora Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication Clin Gastroenterol Hepatol 6 2008 759 764
3. M. Steinhoff, J. Buddenkotte, J. Aubert, M. Sulk, P. Novak, and V.D. Schwab Clinical, cellular, and molecular aspects in the pathophysiology of rosacea J Invest Dermatol Symp Proc 15 2011 2 11
4. F.C. Westall Molecular mimicry revisited: gut bacteria and multiple sclerosis J Clin Microbiol 44 2006 2099 2104